A. Simonds (London, United Kingdom), A. Yorgancioglu (Konak, Turkey)
Including the ALERT sessions (Abstracts Leading to Evolution in Respiratory Medicine Trials), these formats showcase important and very late-breaking clinical trial data from all respiratory disease areas. Presenters, session chairs and viewers will take part lively discussions on the presented trials.
Clinically relevant effects on physical activity with web-based self-management support in people with COPD: a randomized controlled trial T. Stenlund (Umeå, Sweden), Å. Karlsson (Umeå, Sweden), A. Nyberg (Umeå, Sweden), P. Liv (Umeå, Sweden), K. Wadell (Umeå, Sweden)
| |
Effect of an immediate, remote smoking cessation intervention vs usual care among participants enrolled in lung health check: QuLIT2 study. W. Parris (London, United Kingdom), K. Philip (London, United Kingdom), N. Kaur-Gill (London, United Kingdom), D. Flannery (London, United Kingdom), S. Buttery (London, United Kingdom), E. Bartlett (London, United Kingdom), A. Devaraj (London, United Kingdom), J. Addis (London, United Kingdom), S. Kemp (London, United Kingdom), M. Chen (London, United Kingdom), J. Derbyshire (London, United Kingdom), K. Morris (London, United Kingdom), A. Laverty (London, United Kingdom), N. Hopkinson (London, United Kingdom)
| |
Effect of pharmacy-supported digital medicine program on asthma control C. Onnis (Cagliari, Italy), S. Ferri (Rozzano, Italy), J. Van Der Palen (Enschede, Netherlands), J. Pritchard (Leicester, United Kingdom), M. Citterio (Osnago, Italy), G. Recchia (Milano, Italy), L. Ponti (Milano, Italy), M. Grinovero (Milano, Italy)
| |
Wrap-up by discussant and discussion A. Aliverti (Milan, Italy)
| |
Antibiotic use during severe RSV bronchiolitis may increase subsequent recurrent wheeze risk A. Beigelman (Petah Tikva, Israel), M. Srinivasan (St. Louis, United States), C. Goss (St. Louis, United States), J. Wang (St. Louis, United States), Y. Zhou (Farmington, United States), K. True (St. Louis, United States), E. Ahrens (St. Louis, United States), D. Burgdorf (St. Louis, United States), M. Haslam (St. Louis, United States), J. Boomer (Kansas City, United States), S. Bram (St. Louis, United States), C. Burnham (St. Louis, United States), T. Casper (St. Louis, United States), A. Coverstone (St. Louis, United States), W. Kanchongkittiphon (Bangkok, Thailand), C. Kuklinski (St. Louis, United States), G. Storch (St. Louis, United States), M. Wallace (St. Louis, United States), H. Yin-Declue (Kansas City, United States), M. Castro (Kansas City, United States), K. Schechtman (St. Louis, United States), L. Bacharier (Nashville, United States)
| |
Inhaled corticosteroids to improve lung function in survivors of very preterm birth: PICSI RCT S. Simpson (Perth (WA), Australia), R. Urs (Perth (WA), Australia), D. Evans (Perth (WA), Australia), T. Bradshaw (Perth (WA), Australia), R. Foong (Perth (WA), Australia), E. Smith (Perth (WA), Australia), J. Gibbons (Perth (WA), Australia), A. Wilson (Perth (WA), Australia)
| |
Wrap-up by discussant and discussion D. Drummond (Paris, France)
| |